HALO logo
halo search icon
Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc.
DRUG · NAS

Bright Minds Biosciences Inc.

US$82.78

Price Arrow8.24 (11.05%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Bright Minds Biosciences Inc. Overview

DRUG Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About DRUG

icon

Website

Bright Minds Biosciences Inc.

icon

Telephone

1.647.407.2515

icon

Address

Suite 900, 400 North Aberdeen Street, Chicago, IL 60642

Description

Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in Chicago, IL.

DRUG Price Chart

Key Stats

Market Cap

US$729.53M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 23.17 - 123.75

Trade Value (12mth)

US$2,316,305.00

1 week

-3.78%

1 month

-14.73%

YTD

-10.69%

1 year

144.96%

All time high

123.75

Key Fundamentals

EPS 3 yr Growth

-73.20%

EBITDA Margin

0.00%

Operating Cashflow

-$6m

Free Cash Flow Return

-19.70%

ROIC

-27.70%

Interest Coverage

-385.60

Quick Ratio

36.10

Other Data

Shares Outstanding (Fully Diluted)

8m

HALO Sector

Healthcare

Next Company Report Date

17-Dec-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

DRUG Announcements

Latest Announcements

DateAnnouncements
20 May 26
13 February 26
10 January 26
09 January 26
09 January 26

DRUG Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.47-0.48-1.27locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.47-0.48-1.27locklocklock
Growth
%locklocklocklock6967.5-166.2locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Bright Minds Biosciences Inc. (DRUG:NAS)?
Halo FAQ
The current share price of Bright Minds Biosciences Inc. (DRUG:NAS) is USD$82.78.
What is the 52-week high share price for Bright Minds Biosciences Inc. (DRUG:NAS)?
Halo FAQ
The 52-week high share price for Bright Minds Biosciences Inc. (DRUG:NAS) is USD$123.75.
What is the 52-week low share price for Bright Minds Biosciences Inc. (DRUG:NAS)?
Halo FAQ
The 52-week low share price for Bright Minds Biosciences Inc. (DRUG:NAS) is USD$23.17.
What is the dividend yield for Bright Minds Biosciences Inc. (DRUG:NAS)?
Halo FAQ
Bright Minds Biosciences Inc. (DRUG:NAS) does not pay a dividend.
What was Bright Minds Biosciences Inc. (DRUG:NAS) last dividend payment?
Halo FAQ
Bright Minds Biosciences Inc. (DRUG:NAS) does not pay a dividend.
What is the franking level for Bright Minds Biosciences Inc. (DRUG:NAS)?
Halo FAQ
Bright Minds Biosciences Inc. (DRUG:NAS) has a franking level of 0.00%.
In which sector is Bright Minds Biosciences Inc. (DRUG:NAS) classified?
Halo FAQ
Bright Minds Biosciences Inc. (DRUG:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.